142 related articles for article (PubMed ID: 22538301)
1. Aspirin users attending for NHS bowel cancer screening have less colorectal neoplasia: chemoprevention or false-positive faecal occult blood testing?
Lee TJ; Hull MA; Rajasekhar PT; Clifford GM; Ritchie M; James P; McNally RJ; Rutter MD; Rees CJ
Digestion; 2012; 85(4):278-81. PubMed ID: 22538301
[TBL] [Abstract][Full Text] [Related]
2. High yield of colorectal neoplasia detected by colonoscopy following a positive faecal occult blood test in the NHS Bowel Cancer Screening Programme.
Lee TJ; Clifford GM; Rajasekhar P; Rutter MD; Kometa S; Ritchie MC; Waddup G; Nylander D; McNally RJ; Rees CJ
J Med Screen; 2011; 18(2):82-6. PubMed ID: 21852700
[TBL] [Abstract][Full Text] [Related]
3. The impact of aspirin, statins and ACE-inhibitors on the presentation of colorectal neoplasia in a colorectal cancer screening programme.
Mansouri D; McMillan DC; Roxburgh CS; Crighton EM; Horgan PG
Br J Cancer; 2013 Jul; 109(1):249-56. PubMed ID: 23778525
[TBL] [Abstract][Full Text] [Related]
4. Symptoms do not predict colorectal cancer in an FOB screened population.
Saldanha JD; Moug SJ; Linton K; Diament RH
Scott Med J; 2013 May; 58(2):95-8. PubMed ID: 23728754
[TBL] [Abstract][Full Text] [Related]
5. Medications with anticoagulant properties increase the likelihood of a negative colonoscopy in faecal occult blood test population screening.
Clarke P; Jack F; Carey FA; Steele RJ
Colorectal Dis; 2006 Jun; 8(5):389-92. PubMed ID: 16684082
[TBL] [Abstract][Full Text] [Related]
6. A further piece of the puzzle: positive FOBT, colonoscopy, aspirin and the prevention of colorectal cancer.
Ockenga J
Digestion; 2012; 85(4):276-7. PubMed ID: 22538259
[No Abstract] [Full Text] [Related]
7. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme.
Lee TJ; Rutter MD; Blanks RG; Moss SM; Goddard AF; Chilton A; Nickerson C; McNally RJ; Patnick J; Rees CJ
Gut; 2012 Jul; 61(7):1050-7. PubMed ID: 21940723
[TBL] [Abstract][Full Text] [Related]
8. Optimising faecal occult blood screening:retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm.
Geraghty J; Butler P; Seaman H; Snowball J; Sarkar S; Blanks R; Halloran S; Bodger K; Rees CJ
Br J Cancer; 2014 Nov; 111(11):2156-62. PubMed ID: 25225905
[TBL] [Abstract][Full Text] [Related]
9. Predictors of advanced colorectal neoplasia at initial and surveillance colonoscopy after positive screening immunochemical faecal occult blood test.
Botteri E; Crosta C; Bagnardi V; Tamayo D; Sonzogni AM; De Roberto G; de Leone A; Lowenfels A; Maisonneuve P
Dig Liver Dis; 2016 Mar; 48(3):321-6. PubMed ID: 26739617
[TBL] [Abstract][Full Text] [Related]
10. Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program.
Wieten E; de Klerk CM; van der Steen A; Ramakers CR; Kuipers EJ; Hansen BE; Lansdorp-Vogelaar I; Bossuyt PM; Dekker E; Spaander MCW
Gastroenterology; 2018 Nov; 155(5):1392-1399.e5. PubMed ID: 30055170
[TBL] [Abstract][Full Text] [Related]
11. Non-neoplastic findings at colonoscopy after positive faecal occult blood testing: data from the English Bowel Cancer Screening Programme.
Bevan R; Lee TJ; Nickerson C; Rubin G; Rees CJ;
J Med Screen; 2014 Jun; 21(2):89-94. PubMed ID: 24644029
[TBL] [Abstract][Full Text] [Related]
12. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.
Hardcastle JD; Chamberlain JO; Robinson MH; Moss SM; Amar SS; Balfour TW; James PD; Mangham CM
Lancet; 1996 Nov; 348(9040):1472-7. PubMed ID: 8942775
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Direct Oral Anticoagulants, Warfarin, Aspirin and Thienopyridine on the Performance of Immunochemical, Faecal, Occult Blood Tests.
Niikura R; Yamada A; Fujishiro M; Tanaka K; Matsuda K; Saito Y; Ohtsuka K; Oda I; Katada C; Kato M; Kida M; Kobayashi K; Hoteya S; Horimatsu T; Kodashima S; Matsuda T; Muto M; Yamamoto H; Ryozawa S; Iwakiri R; Kutsumi H; Miyata H; Kato M; Haruma K; Fujimoto K; Uemura N; Kaminishi M; Shinozaki T; Tajiri H; Koike K
Digestion; 2019; 100(2):117-126. PubMed ID: 30408803
[TBL] [Abstract][Full Text] [Related]
14. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial: Flexible sigmoidoscopy as an adjunct to faecal occult blood testing in population screening.
Steele RJ; Carey FA; Stanners G; Lang J; Brand J; Brownlee LA; Crichton EM; Winter JW; Phull PS; Mowat C; Strachan JA; Digan AM; Fraser CG
J Med Screen; 2020 Jun; 27(2):59-67. PubMed ID: 31690179
[TBL] [Abstract][Full Text] [Related]
16. The role of faecal calprotectin in the identification of colorectal neoplasia in patients attending for screening colonoscopy.
Ross FA; Park JH; Mansouri D; Little C; Di Rollo DG; Combet E; Van Wyk H; Horgan PG; McMillan DC; Roxburgh CSD
Colorectal Dis; 2022 Feb; 24(2):188-196. PubMed ID: 34614299
[TBL] [Abstract][Full Text] [Related]
17. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
[TBL] [Abstract][Full Text] [Related]
18. Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme.
Wilson S; Taskila T; Ismail T; Stocken DD; Martin A; Redman V; Wakelam M; Perry I; Hobbs R
BMC Cancer; 2009 Jan; 9():36. PubMed ID: 19175925
[TBL] [Abstract][Full Text] [Related]
19. Ethnic variation in colorectal cancer risk following a positive faecal occult blood test in an English bowel cancer screening programme centre.
Padmanabhan H; Widlak M; Nevill A; McKaig B; Brookes M; Veitch A
Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1281-5. PubMed ID: 26267240
[TBL] [Abstract][Full Text] [Related]
20. Effect of faecal occult blood testing on colorectal cancer mortality in the surveillance of subjects at moderate risk of colorectal neoplasia: a case-control study.
Lamah M; Norris J; Caffarey SM; Broughton M; Marks CG
Int J Colorectal Dis; 2001 Sep; 16(5):313-7. PubMed ID: 11686530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
